Cookie Notice
By continuing to use this website, you consent to our use of cookies and the other terms of our Privacy Policy.
For more information, please visit our Privacy Policy.
The Chiesi CareDirect Wellness Program is a patient support program designed to give your eligible patients options and choices. Patients enrolled in the Chiesi CareDirect Wellness Program receive all their benefits information and updates in one place, saving time, and manage their wellness redemptions from their mobile phones. Eligible patients can choose between:
Earn nutritional supplements, probiotics,
and vitamins with every approved prescription.
Redeem points for items such as medical equipment, masks, smart scales, and fitness equipment.
Actual product, packaging, and materials may vary and are subject to substitution or replacement at any time.
†Restrictions apply. Please see full Terms and Conditions below.
Fax the completed form to 1-866-410-6241, or email it to chiesicaredirect@caremetx.com.
†Restrictions apply. Please see full Terms and Conditions below.
§Fax the completed form to 1-866-410-6241 or email it to chiesicaredirect@caremetx.com.
Unless otherwise indicated, the Site is Chiesi’s proprietary property and all source code, databases, functionality, software, website designs, audio, video, text, photographs, and graphics on the Site (collectively, the “Content”), all third party logos, trademarks, icons, and product images (collectively, the “Products”) remain the properties of their respective owners. Unless specifically identified as such, use of third party information does not indicate any relationship, sponsorship, or endorsement between Chiesi and the owners of these Products. Any references by Chiesi to third party Products is to identify the corresponding third party goods and shall be considered nominative fair use under trademark and copyright laws.
*Co-Pay Assistance Program Eligibility and Details:
Restrictions apply. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the BRONCHITOL Patient Assistance Program but may be eligible for other non-financial components of the program. Please see full Terms and Conditions for additional eligibility requirements.
Restrictions apply. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the BRONCHITOL Quick Start Program but may be eligible for other non-financial components of the program. Please see full Terms and Conditions for additional eligibility requirements.
How to administer
BRONCHITOL is not intended to be used as a rescue medication. Inhaler and blister pack are not actual size and are for representation only. Use an inhaled bronchodilator 5–15 minutes before taking BRONCHITOL.
BRONCHITOL is contraindicated in patients with hypersensitivity to mannitol or to any of the capsule components. BRONCHITOL is contraindicated in patients who fail to pass the BRONCHITOL Tolerance Test (BTT).
BRONCHITOL can cause bronchospasm, which can be severe in susceptible patients. Because of the risk of bronchospasm, prior to prescribing BRONCHITOL, patients must pass the BRONCHITOL Tolerance Test (BTT). The BTT must be administered under the supervision of a healthcare practitioner who can treat severe bronchospasm.
Patients who pass the BRONCHITOL tolerance test (BTT) may experience bronchospasm with add-on maintenance therapy with BRONCHITOL. Patients should premedicate with an inhaled short-acting bronchodilator prior to each administration of BRONCHITOL. If bronchospasm occurs, immediately discontinue BRONCHITOL and treat bronchospasm with an inhaled short-acting bronchodilator.
Hemoptysis can occur with BRONCHITOL use. Monitor patients with history of episodes of hemoptysis. If hemoptysis occurs, discontinue use of BRONCHITOL.
Most common adverse reactions (≥3%) include cough, hemoptysis, oropharyngeal pain, vomiting, bacteria sputum identified, pyrexia, and arthralgia.
BRONCHITOL® (mannitol) inhalation powder is a sugar alcohol indicated as add-on maintenance therapy to improve pulmonary function in adult patients 18 years of age and older with cystic fibrosis. Use BRONCHITOL only in adults who have passed the BRONCHITOL Tolerance Test.
Open
Close